{
  "image_filename": "figure_p3_mrg_det_2_000.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/figure_p3_mrg_det_2_000.png",
  "image_type": "Figure",
  "page_number": 3,
  "block_id": "mrg_det_2_000",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "Figure shows a schematic of Kaiser Permanente Northern California (KPNC) health care facilities of various sizes, allocation of similarly sized facilities into two blocks (A and B), and a table displaying weekly alternation of two vaccine formulations (SD-IIV4 and RIV4) across facilities for four weeks. does not support the claim because the figure describes randomization of facilities and weekly alternation between standard-dose inactivated vaccine (SD-IIV4) and recombinant quadrivalent influenza vaccine (RIV4), and contains no data on Flublok or antigenic match with WHO/FDA-selected strains.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Figure shows a schematic of Kaiser Permanente Northern California (KPNC) health care facilities of various sizes, allocation of similarly sized facilities into two blocks (A and B), and a table displaying weekly alternation of two vaccine formulations (SD-IIV4 and RIV4) across facilities for four weeks.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the figure describes randomization of facilities and weekly alternation between standard-dose inactivated vaccine (SD-IIV4) and recombinant quadrivalent influenza vaccine (RIV4), and contains no data on Flublok or antigenic match with WHO/FDA-selected strains.",
    "confidence_notes": null
  }
}